AffirmHealth Blog

Image showing that a prescription drug monitoring program communicates both ways with pharmacies, allows health care providers to obtain information. In addition, state insurance programs, healthcare licensure boards, state health departments, and law enforcement can also get information from the program.

PDMP's: A discussion For and Against a State By State Monitoring Program

Sep 18, 2018 10:00:00 AM by Jody Lutz posted in Healthcare, PDMPs, Clinician Perspective, chronic pain, Pain Management, Clinical Tools, State Opioid Prescibing Guidelines, Opioid Prescribing Guidelines, prescriber compliance, opioid prescribing, clinical practice improvement activities, patient risk, opioid legislation, Healthcare Databases, controlled substances, electronic decisions support

Pharmacy Times reports that, "The first PDMP program was enacted by New York State in 1918 and was used to monitor prescriptions for cocaine, codeine, heroin, morphine, and opium. With this program, pharmacists were required to report copies of prescriptions to the health department within 24 hours."

Read More
Weekend Round Up

Weekend Round Up: Healthcare Databases, Chronic Pain Patients Feel Caught in Debate and State Updates for Florida, and Connecticut

Jul 8, 2018 7:57:02 PM by Jody Lutz posted in Healthcare, Opioid Epidemic, Opioid Misuse, chronic pain, Integrated Pain, Opioid Therapy, Opioid Doses, Smarter Pain Management, Guidelines, Clinical Tools, State Opioid Prescibing Guidelines, Opioid Prescribing Guidelines, Chronic Pain Guidelines, prescriber compliance, regulations, compliance, opioid prescribing, opioid prescribing compliance, prescription drug monitoring, weekend round up, Medication Assisted Treatment Protocols, tapering, patient safety, Arizona, opioid legislation, opioid abuse, florida, Healthcare Databases, Connecticut, controlled substances

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More
Weekend Round Up

Weekend Round Up: Memorial Day Edition

May 27, 2018 12:49:05 PM by Jody Lutz posted in Healthcare, Opioid Epidemic, Opioid Misuse, Opioid Therapy, prescriber compliance, regulations, prescription drug monitoring, weekend round up, prescribing protocols, Treatment Agreements, Informed Consent, Michigan

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More
Weekend Round Up

Weekend Round Up

May 20, 2018 4:24:30 PM by Jody Lutz posted in Healthcare, Opioid Epidemic, Pain Management, opioid prescribing, weekend round up, patient risk, DEA, Heroin, Migraine Treatment

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More
DEA_TakeBackMark_RGB-2

DEA NATIONAL TAKE BACK

Apr 26, 2018 11:09:33 AM by Jody Lutz posted in Healthcare, Opioid Epidemic, Opioid Prescribing Guidelines, opioid prescribing compliance, patient risk, DEA

 

On Saturday, April 28, from 10 a.m. to 2 p.m. the Drug Enforcement Administration will partner with local agencies across the country for the 15th Take Back Day. This opportunity is another initiative to prevent pill abuse and theft by ridding homes of potentially dangerous expired, unused, and unwanted prescription drugs. The DEA cannot accept liquids or needles or sharps, only pills or patches. The service is free and anonymous.

Read More
Weekend Round Up

Weekend Round Up

Mar 18, 2018 4:00:00 PM by Jody Lutz posted in Insider, Healthcare, PDMPs, Opioid Epidemic, Guidelines, Clinical Tools, prescriber compliance, opioid prescribing, opioid prescribing compliance, weekend round up

Happy Spring Break! A few of the news stories that caught our eye at AffirmHealth this past week.  

Read More

Integrated Pain-Psych Program Cuts Costs by 45%

Mar 27, 2017 7:20:00 AM by Mitch Evans posted in Healthcare, Interventional Pain Management, Opioid Epidemic, chronic pain, Integrated Pain

Let's face two truths about heathcare costs in our country:

  1. We spend over $600 billion annually in pain treatment and resulting lost productivity
  2. The top 1% of 'high utilizers' account for over 27% of total costs

Read More

Generating Pain Management Information in the Opioid Epidemic Era

Mar 21, 2017 7:00:00 AM by Mario Ramirez, MD posted in Healthcare, PDMPs, Clinician Perspective, Opioid Epidemic

In previous blog posts, I’ve written about the work we’re doing at AffirmHealth to combat the growing opioid epidemic in our country. With Dash, we’re working to help clinicians access prescription drug monitoring programs as efficiently as possible with an eye toward driving clinical decision support based on scientific guidelines.

Read More

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

Comments